Molecular Detection Inc. - Product Pipeline Analysis, 2014 Update

Date: September 1, 2014
Pages: 28
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M64C20E4311EN
Leaflet:

Download PDF Leaflet

Molecular Detection Inc. - Product Pipeline Analysis, 2014 Update
Summary

Molecular Detection Inc. (MDI) is medical device company. The company develops and markets diagnostic tools for detection of infectious diseases. Its product segments include Detect-Ready MRSA Swab Lysis Kit, Rotor-Gene, SmartCycler, and LightCycler. MDI is also developing Detect-Ready panels to test for the existence of microbial agents, including foodborne pathogens, C. difficile, and sexually transmitted diseases (STDs). The company markets its product through its brand name Detect-Ready. It distributes its products through distribution centers in Australia, Austria, Belgium, Germany, Ireland, Israel, Luxembourg, the Netherlands, Spain, Switzerland, and the UK. MDI is headquartered in Wayne, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Molecular Detection Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Molecular Detection Inc. Company Snapshot
Molecular Detection Inc. Company Overview
Key Information
Molecular Detection Inc. Pipeline Products and Clinical Trials Overview
Molecular Detection Inc. – Pipeline Analysis Overview
Key Facts
Molecular Detection Inc. - Major Products and Services
Molecular Detection Inc. Pipeline Products by Development Stage
Molecular Detection Inc. Pipeline Products Overview
Detect-Ready MRSA Assay
Detect-Ready MRSA Assay Product Overview
Detect-Ready Test - C.Difficile
Detect-Ready Test - C.Difficile Product Overview
Detect-Ready Test - Sexually Transmitted Disease
Detect-Ready Test - Sexually Transmitted Disease Product Overview
Diagnostic Assay - Bloodstream MRSA
Diagnostic Assay - Bloodstream MRSA Product Overview
Diagnostic Assay - BloodStream VR Infection
Diagnostic Assay - BloodStream VR Infection Product Overview
Diagnostic Panel - Gastrointestinal Diseases
Diagnostic Panel - Gastrointestinal Diseases Product Overview
Molecular Diagnostic Panel - Sepsis
Molecular Diagnostic Panel - Sepsis Product Overview
Molecular Detection Inc. - Key Competitors
Molecular Detection Inc. - Key Employees
Molecular Detection Inc. - Key Employee Biographies
Molecular Detection Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Molecular Detection Inc., Recent Developments
Feb 07, 2013: Molecular Detection Receives Notice Of Acceptance For US Patent Issues And European Patent Application
Mar 30, 2012: Molecular Detection To Launch Improved Version Of Detect-Ready MRSA Panel At 2012 ECCMID Congress
Jul 19, 2011: MDI And Eldan Announce Distribution Agreement For Detect-Ready MRSA Panel In Israel
Nov 03, 2010: MDI Receives $244,500 Federal Grant To Support US Validation Trial For Detect-Ready MRSA Screening Panel
Oct 26, 2010: MDI Announces MSSA Label Expansion And Benelux Distribution Agreement For Detect-Ready MRSA Screening Test
Oct 13, 2010: MDI Announces Detect-Ready MRSA Assay Demonstrates Strong Performance In Independent Comparative Study
Sep 22, 2010: MDI Enters Into Agreement With Integrated Sciences For Distribution Of Detect-Ready MRSA Assay In Australia
Jul 13, 2010: MDI Commercializes Detect-Ready MRSA Assay In Spain Through Palex Medical
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Molecular Detection Inc., Key Facts
Molecular Detection Inc. Pipeline Products and Clinical Trials Overview
Molecular Detection Inc. Pipeline Products by Equipment Type
Molecular Detection Inc. Pipeline Products by Indication
Molecular Detection Inc., Key Facts
Molecular Detection Inc., Major Products and Services
Molecular Detection Inc. Number of Pipeline Products by Development Stage
Molecular Detection Inc. Pipeline Products Summary by Development Stage
Detect-Ready MRSA Assay - Product Status
Detect-Ready MRSA Assay - Product Description
Detect-Ready Test - C.Difficile - Product Status
Detect-Ready Test - C.Difficile - Product Description
Detect-Ready Test - Sexually Transmitted Disease - Product Status
Detect-Ready Test - Sexually Transmitted Disease - Product Description
Diagnostic Assay - Bloodstream MRSA - Product Status
Diagnostic Assay - Bloodstream MRSA - Product Description
Diagnostic Assay - BloodStream VR Infection - Product Status
Diagnostic Assay - BloodStream VR Infection - Product Description
Diagnostic Panel - Gastrointestinal Diseases - Product Status
Diagnostic Panel - Gastrointestinal Diseases - Product Description
Molecular Diagnostic Panel - Sepsis - Product Status
Molecular Diagnostic Panel - Sepsis - Product Description
Molecular Detection Inc., Key Employees
Molecular Detection Inc., Key Employee Biographies
Molecular Detection Inc., Subsidiaries

LIST OF FIGURES

Molecular Detection Inc. Pipeline Products by Equipment Type
Molecular Detection Inc. Pipeline Products by Development Stage
Skip to top


Ask Your Question

Molecular Detection Inc. - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: